CORAL GABLES, Fla., Sept. 21 /PRNewswire/ — Stiefel Laboratories, Inc. announced today that MimyX(R) Cream, a steroid-free, topical prescription therapy for managing the signs and symptoms of atopic dermatitis, is now available in a new, larger, 140g tube at a substantially lower cost per gram than the original 70g tube and several other prescription treatments. Introduced in October 2005, MimyX Cream has been clinically demonstrated to be successful when used alone or with other products in helping patients who suffer from atopic dermatitis, better known as eczema, manage their dry, itchy skin condition. The new 140g tube is available at pharmacies nationwide. Patients may realize a savings over the original size at the pharmacy because of the new lower cost per gram or their co-pay may remain the same for twice the amount of MimyX Cream.
“This new 140g tube may be more convenient for patients who experience the symptoms of eczema on large areas of the body and may provide a cost savings,” said Dr. Leon Kircik, founder and director of Physicians Skin Care, Louisville, Kentucky. He continued, “In my patients I have found MimyX Cream to be effective non-steroidal treatment for the relief of signs and symptoms of atopic dermatitis, with a great safety profile. The fact that it is hypoallergenic is also helpful for many patients.”
About Atopic Dermatitis (Eczema)
Atopic dermatitis is often simply referred to as “eczema.” It is characterized by extremely itchy skin that leads to persistent scratching. That scratching produces redness, swelling, cracking, “weeping” of clear fluid, and finally, crusting and scaling.
According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), more than 15 million people in the U.S. have symptoms of atopic dermatitis. In addition, children are more commonly affected than adults, with 90 percent of atopic dermatitis cases diagnosed by age 5. Roughly 60 percent of infants affected continue to have one or more symptoms of atopic dermatitis into adulthood. Atopic dermatitis can cause social and emotional stress associated with changes in physical appearance and its uncomfortable symptoms.
About MimyX Cream
MimyX Cream is available by prescription and only your healthcare provider can determine if it is right for you. MimyX Cream is indicated to manage and relieve the burning and itching experienced with eczema. MimyX Cream is not to be used in patients who have sensitivity to the ingredients of the product. Adverse events seen in clinical studies were mild itching, burning, redness and other localized skin reactions. If you experience worsening of your condition, or adverse symptoms, contact your health professional. MimyX Cream is for external use only. See full prescribing information for complete product information at http://www.stiefel.com/products/inserts/Mimyx%20PI.pdf.
About Stiefel Laboratories, Inc.
Founded in 1847, Stiefel Laboratories is the world’s largest independent pharmaceutical company specializing in dermatology. Its wholly-owned global network is comprised of more than 30 subsidiaries, including: manufacturing plants in six countries; R&D facilities on three continents; and products marketed in more than 100 countries worldwide. Research and development efforts are complimented by aggressively seeking acquisitions of dermatological product lines and companies around the world. To learn more about Stiefel Laboratories, Inc. visit http://www.stiefel.com/.
Stiefel Laboratories, Inc.
CONTACT: Denise Ulrich of Stiefel Laboratories, Inc., +1-678-765-4104,Cell, +1-770-656-9338, or [email protected]
Web site: http://www.stiefel.com/http://www.stiefel.com/products/inserts/Mimyx%20PI.pdf
Comments